OSTEOPORE LIMITED - Announcements

0.00%

1.0¢

Market Cap $2.372M

Healthcare Medical Devices

Osteopore Limited is a regenerative medicine company engaged in three-dimensional... Osteopore Limited is a regenerative medicine company engaged in three-dimensional (3D)-printed biomimetic and bioresorbable implants. The Company’s commercialized products are designed to enable natural bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

OSX	OSX ortho product successful in Vietnam hospital tender bids	PRICE SENSITIVE	04/08/25	373.93KB	Share
OSX	Activities Report June 2025 and Appendix 4C	PRICE SENSITIVE	31/07/25	11.97MB	Share
OSX	Business progress update, Zimmer Biomet sales units grows 3x	PRICE SENSITIVE	29/07/25	241.7KB	Share
OSX	Osteopore gains access to Switzerland	PRICE SENSITIVE	14/07/25	405.77KB	Share
OSX	Further Drawdown of T1 of the Redeemable Convertible Notes	PRICE SENSITIVE	23/05/25	350.84KB	Share
OSX	Further Drawdown of T1 of the Redeemable Convertible Notes	PRICE SENSITIVE	16/05/25	347.94KB	Share
OSX	Activities Report March 2025 and Appendix 4C	PRICE SENSITIVE	29/04/25	5.85MB	Share
OSX	Osteopore secures EU market approvals for custom implants	PRICE SENSITIVE	09/04/25	229.76KB	Share
OSX	Reinstatement to Quotation	PRICE SENSITIVE	08/04/25	413.27KB	Share
OSX	Further Drawdown of T1 of the Redeemable Convertible Notes	PRICE SENSITIVE	07/04/25	608.67KB	Share
OSX	Suspension from Quotation	PRICE SENSITIVE	01/04/25	92.04KB	Share
OSX	Convertible Note Prospectus	PRICE SENSITIVE	28/03/25	661.89KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/25	304.96KB	Share
OSX	Drawdown of Tranche 1 of the Redeemable Convertible Notes	PRICE SENSITIVE	14/02/25	347.82KB	Share
OSX	Convertible Note Prospectus	PRICE SENSITIVE	12/02/25	1.71MB	Share
OSX	Activities Report December 2024 and Appendix 4C	PRICE SENSITIVE	31/01/25	6.31MB	Share
OSX	OSX enters agreement to issue redeemable convertible notes	PRICE SENSITIVE	24/12/24	346.67KB	Share
OSX	OSX partners scientists to drive regeneration innovation	PRICE SENSITIVE	04/11/24	324.16KB	Share
OSX	Activities Report September 2024 and Appendix 4C	PRICE SENSITIVE	31/10/24	5.15MB	Share
OSX	Osteopore to raise A$20m via redeemable convertible note	PRICE SENSITIVE	27/09/24	358.75KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	30/08/24	774.58KB	Share
OSX	OSX and University of Chile complete bone implant studies	PRICE SENSITIVE	22/08/24	389.84KB	Share
OSX	Activities Update Qtr Ending June 2024 and Appendix 4C	PRICE SENSITIVE	31/07/24	15.47MB	Share
OSX	Osteopore strikes Exclusive Distribution with Zimmer Biomet	PRICE SENSITIVE	16/07/24	383.98KB	Share
OSX	*A$18.7m Osteopore, NDCS and ASTAR project hits milestones**	PRICE SENSITIVE	06/06/24	406.07KB	Share
OSX	OSX and SingHealth partner on Global Centre of Excellence	PRICE SENSITIVE	14/05/24	842.63KB	Share
OSX	Osteopore successfully raises A$2.9m from Entitlement Offer	PRICE SENSITIVE	07/05/24	383.2KB	Share
OSX	Activities Update Qtr Ending March 2024 and Appendix 4C	PRICE SENSITIVE	30/04/24	4.45MB	Share
OSX	Response to ASX Price and Volume Query	PRICE SENSITIVE	23/04/24	888.9KB	Share
OSX	Trading Halt	PRICE SENSITIVE	23/04/24	770.63KB	Share
OSX	Pause in Trading	PRICE SENSITIVE	23/04/24	116.23KB	Share
OSX	Reinstatement to Official Quotation	PRICE SENSITIVE	16/04/24	413.16KB	Share
OSX	Response to ASX Query Letter	PRICE SENSITIVE	15/04/24	997.19KB	Share
OSX	Osteopore extends Bridging Loan maturity date	PRICE SENSITIVE	10/04/24	469.06KB	Share
OSX	Replacement Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	04/04/24	886.15KB	Share
OSX	Update to Replacement Prospectus for Entitlement Offer	PRICE SENSITIVE	03/04/24	351.09KB	Share
OSX	Replacement Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	02/04/24	987.92KB	Share
OSX	Suspension from Quotation	PRICE SENSITIVE	02/04/24	91.71KB	Share
OSX	Suspension from Quotation	PRICE SENSITIVE	28/03/24	700.87KB	Share
OSX	Osteopore secures Singapore and Vietnam market approvals	PRICE SENSITIVE	27/03/24	344.23KB	Share
OSX	Prospectus for Renounceable Rights Issue	PRICE SENSITIVE	13/03/24	861.28KB	Share
OSX	OSX Entitlement Offer to support growth	PRICE SENSITIVE	13/03/24	369.97KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	29/02/24	295.7KB	Share
OSX	Activities Update Qtr Ending December 2023 and Appendix 4C	PRICE SENSITIVE	31/01/24	3.24MB	Share
OSX	Notice of General Meeting	PRICE SENSITIVE	23/01/24	2.21MB	Share
OSX	Osteopore signs Bridging Loan agreement	PRICE SENSITIVE	28/12/23	371.4KB	Share
OSX	Activities Update Qtr Ending September 2023 and Appendix 4C	PRICE SENSITIVE	31/10/23	3.5MB	Share
OSX	MOU with Temasek-linked Innoventures - Orthopaedics in China	PRICE SENSITIVE	12/09/23	384.17KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/23	613.27KB	Share
OSX	Activities Update Qtr Ending June 2023 and Appendix 4C	PRICE SENSITIVE	31/07/23	4.12MB	Share
OSX	OSX receives A$10m commitment for commercialisation in China	PRICE SENSITIVE	25/07/23	389.6KB	Share
OSX	Osteopore strengthens Board & Management by key appointments	PRICE SENSITIVE	18/07/23	397.82KB	Share
OSX	Strategic Partnership for Clinical R&D in China worth $4M	PRICE SENSITIVE	08/06/23	269.56KB	Share
OSX	Largest South African Medical Insurer provides cover for OSX	PRICE SENSITIVE	16/05/23	278.1KB	Share
OSX	Activities Update Qtr Ending March 2023 and Appendix 4C	PRICE SENSITIVE	28/04/23	3.43MB	Share
OSX	OSX Successfully transitions to EU Medical Device Regulation	PRICE SENSITIVE	27/04/23	238.93KB	Share
OSX	Reinstatement of Security Class to Quotation	PRICE SENSITIVE	26/04/23	412.9KB	Share
OSX	Security Class Suspension from Quotation	PRICE SENSITIVE	24/04/23	416.22KB	Share
OSX	Non-Renounceable Entitlement Offer - Results	PRICE SENSITIVE	24/04/23	233.65KB	Share
OSX	OSX Strengthens Presence in the Eastern Region of the USA	PRICE SENSITIVE	11/04/23	237.94KB	Share
OSX	OSX Completes Acquisition to Accelerate Revenue Growth	PRICE SENSITIVE	31/03/23	235.22KB	Share
OSX	Non-Renounceable Entitlement Offer Prospectus	PRICE SENSITIVE	13/03/23	655.44KB	Share
OSX	Non-Renounceable Entitlement Offer	PRICE SENSITIVE	13/03/23	225.78KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/23	214.39KB	Share
OSX	Activities Update Qtr Ending December 2022 and Appendix 4C	PRICE SENSITIVE	31/01/23	619.31KB	Share
OSX	Integration of Acquired Business for Higher Sales & Margin	PRICE SENSITIVE	23/01/23	269.81KB	Share
OSX	Reinstatement to Official Quotation	PRICE SENSITIVE	22/12/22	404.26KB	Share
OSX	Firm Commitments and Non-Binding Proposed Acquisition	PRICE SENSITIVE	22/12/22	258.31KB	Share
OSX	Suspension from Official Quotation	PRICE SENSITIVE	21/12/22	561.44KB	Share
OSX	Trading Halt	PRICE SENSITIVE	19/12/22	639.28KB	Share
OSX	Increased presence and commercial opportunities across SEA	PRICE SENSITIVE	08/12/22	483.33KB	Share
OSX	Activities Update Qtr Ending September 2022 and Appendix 4C	PRICE SENSITIVE	31/10/22	516.48KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/22	752.78KB	Share
OSX	Osteopore Moves Closer to China Market Entry	PRICE SENSITIVE	23/08/22	247.2KB	Share
OSX	Activities Update Qtr Ending June 2022 and Appendix 4C	PRICE SENSITIVE	25/07/22	776.56KB	Share
OSX	OSX Enter Oral & Maxillofacial Market in Australia & NZ	PRICE SENSITIVE	10/05/22	407.05KB	Share
OSX	Activities Update Qtr Ending March 2022 and Appendix 4C	PRICE SENSITIVE	29/04/22	1.06MB	Share
OSX	SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures	PRICE SENSITIVE	14/03/22	341.79KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/22	256.14KB	Share
OSX	Activities Update Qtr Ending December 2021 and Appendix 4C	PRICE SENSITIVE	28/01/22	503.6KB	Share
OSX	Osteopore secures A$19m clinical-industrial partnership	PRICE SENSITIVE	13/12/21	270.16KB	Share
OSX	Activities Update Qtr Ending September 2021 and Appendix 4C	PRICE SENSITIVE	29/10/21	547.06KB	Share
OSX	SHG: CSIRO Collaboration for AI-based Tool	PRICE SENSITIVE	19/10/21	236.57KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/21	1MB	Share
OSX	Activities Update Qtr Ending June 2021 and Appendix 4C	PRICE SENSITIVE	30/07/21	547.07KB	Share
OSX	Activities Update Qtr Ending March 2021 and Appendix 4C	PRICE SENSITIVE	30/04/21	530.66KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	26/02/21	273.95KB	Share
OSX	Agreement with Terumo Blood and Cell Technologies	PRICE SENSITIVE	01/02/21	241.21KB	Share
OSX	Activities Update Qtr Ending December 2020 and Appendix 4C	PRICE SENSITIVE	29/01/21	615.69KB	Share
OSX	OSX Signs Australian & New Zealand Distribution Agreement	PRICE SENSITIVE	30/10/20	209.14KB	Share
OSX	Activities Update Qtr Ending September 2020 and Appendix 4C	PRICE SENSITIVE	29/10/20	459.4KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/20	756.12KB	Share
OSX	Investor Presentation	PRICE SENSITIVE	21/08/20	2.75MB	Share
OSX	Osteopore Receives Binding Commitments for $8.5m Placement	PRICE SENSITIVE	21/08/20	213.51KB	Share
OSX	Trading Halt	PRICE SENSITIVE	19/08/20	280.14KB	Share
OSX	Activities Update Quarter Ending June 2020 and Appendix 4C	PRICE SENSITIVE	31/07/20	519.49KB	Share
OSX	Development of New 3D Printed Bone Implant	PRICE SENSITIVE	22/07/20	220.02KB	Share
OSX	Clarification on Initial US Distribution Agreement	PRICE SENSITIVE	02/07/20	209.03KB	Share
OSX	Pause In Trading	PRICE SENSITIVE	02/07/20	114.2KB	Share
OSX	Osteopore Signs Initial U.S. Distribution Agreement	PRICE SENSITIVE	02/07/20	211.47KB	Share

OSX OSX ortho product successful in Vietnam hospital tender bids
04/08/25	PRICE SENSITIVE	373.93KB	Share
OSX Activities Report June 2025 and Appendix 4C
31/07/25	PRICE SENSITIVE	11.97MB	Share
OSX Business progress update, Zimmer Biomet sales units grows 3x
29/07/25	PRICE SENSITIVE	241.7KB	Share
OSX Osteopore gains access to Switzerland
14/07/25	PRICE SENSITIVE	405.77KB	Share
OSX Further Drawdown of T1 of the Redeemable Convertible Notes
23/05/25	PRICE SENSITIVE	350.84KB	Share
OSX Further Drawdown of T1 of the Redeemable Convertible Notes
16/05/25	PRICE SENSITIVE	347.94KB	Share
OSX Activities Report March 2025 and Appendix 4C
29/04/25	PRICE SENSITIVE	5.85MB	Share
OSX Osteopore secures EU market approvals for custom implants
09/04/25	PRICE SENSITIVE	229.76KB	Share
OSX Reinstatement to Quotation
08/04/25	PRICE SENSITIVE	413.27KB	Share
OSX Further Drawdown of T1 of the Redeemable Convertible Notes
07/04/25	PRICE SENSITIVE	608.67KB	Share
OSX Suspension from Quotation
01/04/25	PRICE SENSITIVE	92.04KB	Share
OSX Convertible Note Prospectus
28/03/25	PRICE SENSITIVE	661.89KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/25	PRICE SENSITIVE	304.96KB	Share
OSX Drawdown of Tranche 1 of the Redeemable Convertible Notes
14/02/25	PRICE SENSITIVE	347.82KB	Share
OSX Convertible Note Prospectus
12/02/25	PRICE SENSITIVE	1.71MB	Share
OSX Activities Report December 2024 and Appendix 4C
31/01/25	PRICE SENSITIVE	6.31MB	Share
OSX OSX enters agreement to issue redeemable convertible notes
24/12/24	PRICE SENSITIVE	346.67KB	Share
OSX OSX partners scientists to drive regeneration innovation
04/11/24	PRICE SENSITIVE	324.16KB	Share
OSX Activities Report September 2024 and Appendix 4C
31/10/24	PRICE SENSITIVE	5.15MB	Share
OSX Osteopore to raise A$20m via redeemable convertible note
27/09/24	PRICE SENSITIVE	358.75KB	Share
OSX Half Yearly Report and Accounts
30/08/24	PRICE SENSITIVE	774.58KB	Share
OSX OSX and University of Chile complete bone implant studies
22/08/24	PRICE SENSITIVE	389.84KB	Share
OSX Activities Update Qtr Ending June 2024 and Appendix 4C
31/07/24	PRICE SENSITIVE	15.47MB	Share
OSX Osteopore strikes Exclusive Distribution with Zimmer Biomet
16/07/24	PRICE SENSITIVE	383.98KB	Share
OSX *A$18.7m Osteopore, NDCS and ASTAR project hits milestones**
06/06/24	PRICE SENSITIVE	406.07KB	Share
OSX OSX and SingHealth partner on Global Centre of Excellence
14/05/24	PRICE SENSITIVE	842.63KB	Share
OSX Osteopore successfully raises A$2.9m from Entitlement Offer
07/05/24	PRICE SENSITIVE	383.2KB	Share
OSX Activities Update Qtr Ending March 2024 and Appendix 4C
30/04/24	PRICE SENSITIVE	4.45MB	Share
OSX Response to ASX Price and Volume Query
23/04/24	PRICE SENSITIVE	888.9KB	Share
OSX Trading Halt
23/04/24	PRICE SENSITIVE	770.63KB	Share
OSX Pause in Trading
23/04/24	PRICE SENSITIVE	116.23KB	Share
OSX Reinstatement to Official Quotation
16/04/24	PRICE SENSITIVE	413.16KB	Share
OSX Response to ASX Query Letter
15/04/24	PRICE SENSITIVE	997.19KB	Share
OSX Osteopore extends Bridging Loan maturity date
10/04/24	PRICE SENSITIVE	469.06KB	Share
OSX Replacement Prospectus for Renounceable Rights Issue
04/04/24	PRICE SENSITIVE	886.15KB	Share
OSX Update to Replacement Prospectus for Entitlement Offer
03/04/24	PRICE SENSITIVE	351.09KB	Share
OSX Replacement Prospectus for Renounceable Rights Issue
02/04/24	PRICE SENSITIVE	987.92KB	Share
OSX Suspension from Quotation
02/04/24	PRICE SENSITIVE	91.71KB	Share
OSX Suspension from Quotation
28/03/24	PRICE SENSITIVE	700.87KB	Share
OSX Osteopore secures Singapore and Vietnam market approvals
27/03/24	PRICE SENSITIVE	344.23KB	Share
OSX Prospectus for Renounceable Rights Issue
13/03/24	PRICE SENSITIVE	861.28KB	Share
OSX OSX Entitlement Offer to support growth
13/03/24	PRICE SENSITIVE	369.97KB	Share
OSX Appendix 4E Preliminary Final Report
29/02/24	PRICE SENSITIVE	295.7KB	Share
OSX Activities Update Qtr Ending December 2023 and Appendix 4C
31/01/24	PRICE SENSITIVE	3.24MB	Share
OSX Notice of General Meeting
23/01/24	PRICE SENSITIVE	2.21MB	Share
OSX Osteopore signs Bridging Loan agreement
28/12/23	PRICE SENSITIVE	371.4KB	Share
OSX Activities Update Qtr Ending September 2023 and Appendix 4C
31/10/23	PRICE SENSITIVE	3.5MB	Share
OSX MOU with Temasek-linked Innoventures - Orthopaedics in China
12/09/23	PRICE SENSITIVE	384.17KB	Share
OSX Half Yearly Report and Accounts
31/08/23	PRICE SENSITIVE	613.27KB	Share
OSX Activities Update Qtr Ending June 2023 and Appendix 4C
31/07/23	PRICE SENSITIVE	4.12MB	Share
OSX OSX receives A$10m commitment for commercialisation in China
25/07/23	PRICE SENSITIVE	389.6KB	Share
OSX Osteopore strengthens Board & Management by key appointments
18/07/23	PRICE SENSITIVE	397.82KB	Share
OSX Strategic Partnership for Clinical R&D in China worth $4M
08/06/23	PRICE SENSITIVE	269.56KB	Share
OSX Largest South African Medical Insurer provides cover for OSX
16/05/23	PRICE SENSITIVE	278.1KB	Share
OSX Activities Update Qtr Ending March 2023 and Appendix 4C
28/04/23	PRICE SENSITIVE	3.43MB	Share
OSX OSX Successfully transitions to EU Medical Device Regulation
27/04/23	PRICE SENSITIVE	238.93KB	Share
OSX Reinstatement of Security Class to Quotation
26/04/23	PRICE SENSITIVE	412.9KB	Share
OSX Security Class Suspension from Quotation
24/04/23	PRICE SENSITIVE	416.22KB	Share
OSX Non-Renounceable Entitlement Offer - Results
24/04/23	PRICE SENSITIVE	233.65KB	Share
OSX OSX Strengthens Presence in the Eastern Region of the USA
11/04/23	PRICE SENSITIVE	237.94KB	Share
OSX OSX Completes Acquisition to Accelerate Revenue Growth
31/03/23	PRICE SENSITIVE	235.22KB	Share
OSX Non-Renounceable Entitlement Offer Prospectus
13/03/23	PRICE SENSITIVE	655.44KB	Share
OSX Non-Renounceable Entitlement Offer
13/03/23	PRICE SENSITIVE	225.78KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/23	PRICE SENSITIVE	214.39KB	Share
OSX Activities Update Qtr Ending December 2022 and Appendix 4C
31/01/23	PRICE SENSITIVE	619.31KB	Share
OSX Integration of Acquired Business for Higher Sales & Margin
23/01/23	PRICE SENSITIVE	269.81KB	Share
OSX Reinstatement to Official Quotation
22/12/22	PRICE SENSITIVE	404.26KB	Share
OSX Firm Commitments and Non-Binding Proposed Acquisition
22/12/22	PRICE SENSITIVE	258.31KB	Share
OSX Suspension from Official Quotation
21/12/22	PRICE SENSITIVE	561.44KB	Share
OSX Trading Halt
19/12/22	PRICE SENSITIVE	639.28KB	Share
OSX Increased presence and commercial opportunities across SEA
08/12/22	PRICE SENSITIVE	483.33KB	Share
OSX Activities Update Qtr Ending September 2022 and Appendix 4C
31/10/22	PRICE SENSITIVE	516.48KB	Share
OSX Half Yearly Report and Accounts
31/08/22	PRICE SENSITIVE	752.78KB	Share
OSX Osteopore Moves Closer to China Market Entry
23/08/22	PRICE SENSITIVE	247.2KB	Share
OSX Activities Update Qtr Ending June 2022 and Appendix 4C
25/07/22	PRICE SENSITIVE	776.56KB	Share
OSX OSX Enter Oral & Maxillofacial Market in Australia & NZ
10/05/22	PRICE SENSITIVE	407.05KB	Share
OSX Activities Update Qtr Ending March 2022 and Appendix 4C
29/04/22	PRICE SENSITIVE	1.06MB	Share
OSX SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures
14/03/22	PRICE SENSITIVE	341.79KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/22	PRICE SENSITIVE	256.14KB	Share
OSX Activities Update Qtr Ending December 2021 and Appendix 4C
28/01/22	PRICE SENSITIVE	503.6KB	Share
OSX Osteopore secures A$19m clinical-industrial partnership
13/12/21	PRICE SENSITIVE	270.16KB	Share
OSX Activities Update Qtr Ending September 2021 and Appendix 4C
29/10/21	PRICE SENSITIVE	547.06KB	Share
OSX SHG: CSIRO Collaboration for AI-based Tool
19/10/21	PRICE SENSITIVE	236.57KB	Share
OSX Half Yearly Report and Accounts
31/08/21	PRICE SENSITIVE	1MB	Share
OSX Activities Update Qtr Ending June 2021 and Appendix 4C
30/07/21	PRICE SENSITIVE	547.07KB	Share
OSX Activities Update Qtr Ending March 2021 and Appendix 4C
30/04/21	PRICE SENSITIVE	530.66KB	Share
OSX Appendix 4E Preliminary Final Report
26/02/21	PRICE SENSITIVE	273.95KB	Share
OSX Agreement with Terumo Blood and Cell Technologies
01/02/21	PRICE SENSITIVE	241.21KB	Share
OSX Activities Update Qtr Ending December 2020 and Appendix 4C
29/01/21	PRICE SENSITIVE	615.69KB	Share
OSX OSX Signs Australian & New Zealand Distribution Agreement
30/10/20	PRICE SENSITIVE	209.14KB	Share
OSX Activities Update Qtr Ending September 2020 and Appendix 4C
29/10/20	PRICE SENSITIVE	459.4KB	Share
OSX Half Yearly Report and Accounts
31/08/20	PRICE SENSITIVE	756.12KB	Share
OSX Investor Presentation
21/08/20	PRICE SENSITIVE	2.75MB	Share
OSX Osteopore Receives Binding Commitments for $8.5m Placement
21/08/20	PRICE SENSITIVE	213.51KB	Share
OSX Trading Halt
19/08/20	PRICE SENSITIVE	280.14KB	Share
OSX Activities Update Quarter Ending June 2020 and Appendix 4C
31/07/20	PRICE SENSITIVE	519.49KB	Share
OSX Development of New 3D Printed Bone Implant
22/07/20	PRICE SENSITIVE	220.02KB	Share
OSX Clarification on Initial US Distribution Agreement
02/07/20	PRICE SENSITIVE	209.03KB	Share
OSX Pause In Trading
02/07/20	PRICE SENSITIVE	114.2KB	Share
OSX Osteopore Signs Initial U.S. Distribution Agreement
02/07/20	PRICE SENSITIVE	211.47KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.0¢		Change 0.000(0.00%)		Mkt cap ! $2.372M

Open	High	Low	Value	Volume
1.0¢	1.0¢	1.0¢	$22.85K	2.299M

Buyers (Bids)

No.	Vol.	Price($)
29	5334150	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	457451	2

View Market Depth

No.	Vol.	Price($)
29	5334150	0.009
12	3677610	0.008
6	2979428	0.007
6	2950000	0.006
7	2514000	0.005

Price($)	Vol.	No.
0.010	457451	2
0.011	4218790	6
0.012	3276466	8
0.013	2907218	13
0.014	1998484	6

Last trade - 14.17pm 12/08/2025 (20 minute delay)


Last 1.0¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
0.9¢	1.0¢	0.9¢	906491
Last updated 12.58pm 12/08/2025 ?

OSX (ASX) Chart

OSTEOPORE LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available